Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma
Clinical trial NCT01874119 · TERMINATED
Trial details
- NCT number
- NCT01874119
- Sponsor
- St. Louis University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-12-03
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.